GlassScriptPhysician profile
Ferdinand B Banez
NPI 1073656476
$2,559.03
in general payments reported to CMS, 2019-2025
17 companies · $1,117 in 2025
The $1,117 reported for 2025 was more than what 84% of Addiction Psychiatry providers received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $885 · 2020: $126 · 2021: $51.75 · 2022: $114 · 2023: $36.03 · 2024: $229 · 2025: $1,117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,304 · Education: $78.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,303.97 |
| Education | $78.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $427.88 | 2022-2025 | Aristada, Lybalvi, Vivitrol |
| Sunovion Pharmaceuticals INC. | $407.39 | 2019-2021 | |
| Abbvie INC. | $384.35 | 2020-2025 | |
| Otsuka America Pharmaceutical, INC. | $237.55 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $212.94 | 2025 | Cobenfy |
| Lundbeck LLC | $171.25 | 2019-2025 | Rexulti |
| Janssen Pharmaceuticals, INC | $163.74 | 2019-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $145.81 | 2024-2025 | Caplyta |
| Axsome Therapeutics, INC. | $131.55 | 2025 | Auvelity |
| Exact Sciences Corporation | $64.79 | 2024-2025 | Cologuard Collection Kit |
| Emd Serono, INC. | $46.63 | 2023-2025 | Serostim |
| Allergan, INC. | $45.87 | 2019 | |
| Vanda Pharmaceuticals INC. | $42.11 | 2020-2024 | Fanapt, Hetlioz |
| Melinta Therapeutics, LLC | $23.61 | 2019 | |
| Avanir Pharmaceuticals, INC. | $19.10 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $18.35 | 2019 | |
| Janssen Biotech, INC. | $16.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ferdinand Banez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.